During the recent session, Nektar Therapeutics (NASDAQ:NKTR)’s traded shares were 0.84 million, with the beta value of the company hitting 0.56. At the last check
In the last trading session, 1.5 million shares of the Nektar Therapeutics (NASDAQ:NKTR) were traded, and its beta was 0.57. Most recently the company’s share
In the last trading session, 1.39 million shares of the Nektar Therapeutics (NASDAQ:NKTR) were traded, and its beta was 0.57. Most recently the company’s share
Nektar Therapeutics (NASDAQ:NKTR)’s traded shares stood at 3.77 million during the last session, with the company’s beta value hitting 0.58. At the close of trading,
Nektar Therapeutics (NASDAQ:NKTR)’s traded shares stood at 2.36 million during the last session, with the company’s beta value hitting 0.60. At the close of trading,
In last trading session, Nektar Therapeutics (NASDAQ:NKTR) saw 1.85 million shares changing hands with its beta currently measuring 0.61. Company’s recent per share price level
Nektar Therapeutics (NASDAQ:NKTR) has a beta value of 0.57 and has seen 2.6 million shares traded in the last trading session. The company, currently valued
Nektar Therapeutics (NASDAQ:NKTR) has a beta value of 0.58 and has seen 5.97 million shares traded in the last trading session. The company, currently valued
During the last session, Nektar Therapeutics (NASDAQ:NKTR)’s traded shares were 0.84 million, with the beta value of the company hitting 0.61. At the end of
In the last trading session, 1.93 million shares of the Nektar Therapeutics (NASDAQ:NKTR) were traded, and its beta was 0.60. Most recently the company’s share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
